|
172 |
|
2023 |
WAA and HSCT: Engraftment & Immune Cytopenias |
Active |
|
|
|
171 |
|
2023 |
Hemolysis Measurement Standardization |
Active |
|
|
|
170 |
|
2023 |
Donor perceptions on iron management strategies |
Active |
|
|
|
169 |
|
2023 |
Platelet Bacterial Contamination Testing Outcomes in the Era of LVDS |
Active |
|
|
|
168 |
|
2023 |
WearAble Technology for Collecting Health data in the Transfused (WATCH Transfused) |
Active |
|
|
|
167 |
|
2023 |
Geography and patient-ascribed ancestry in anti-M hemolytic disease of the fetus and newborn |
Active |
|
|
|
166 |
|
2022 |
WATCH (WearAble Technology for Collecting Health data) on Donors |
Active |
|
|
|
165 |
|
2022 |
Infusion Related Reactions in Cellular Therapy (INR-RCT) |
Active |
|
|
|
164 |
|
2022 |
Home transfusion project: focus groups |
Active |
|
|
|
163 |
|
2021 |
Application of pi-BAT to adverse events at blood transfusion and stem cell infusion |
Active |
|
|